Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Cell Cycle
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13145 | AGK2 | 304896-28-4 | ≥98% |
|
2009-10-22 | 10.069288267793 | agk2 | sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration | |||
| 13123 | BIO | 667463-62-9 | ≥98% |
|
2009-06-09 | 34.701210226351 | bio | GSK 3 IX; MLS 2052 | GSK-3α GSK-3β inhibitors Cdk cells cycle wnt ESCs differentiation embryonic stem GSK-3a/b GSK3a/b | ||
| 13299 | Bisindolylmaleimide IV | 119139-23-0 | ≥98% |
|
2009-07-29 | 16.360914561957 | bisindolylmaleimide-iv | Arcyriarubin A | PKC PKA staurosporine inhibitors 634199-73-8 | ||
| 13013 |
(−)- |
856925-71-8 | ≥98% |
|
2009-04-16 | 10.958305709024 | -blebbistatin | (S)-Blebbistatin | inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light blebs (-)-(S)-Blebbistatin | ||
| 13165 |
(+)- |
- | ≥98% |
|
2009-04-16 | 6.012928176796 | -blebbistatin | (R)-Blebbistatin | inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light (+)-(R)-Blebbistatin inhibition inhibited | ||
| 13186 |
(±)- |
674289-55-5 | ≥98% |
|
2009-06-09 | 3.006464088398 | -blebbistatin | inhibitors muscles myosin ATPase smooth bleb apoptosis cells migration chemotaxis cytokinesis division growth UV lights | |||
| 13497 | Brd4/HUNK1 Polyclonal Antibody | - |
|
2009-09-22 | 0E-12 | brd4-hunk1-polyclonal-antibody | BET antibodies WB western blots blotting immunoblotting terminus isoforms | ||||
| 10007955 | CAY10498 | 863202-33-9 | >98% |
|
2006-08-02 | 7.727734806630 | cay10498 | 2-phenyl-amino-N6-endo-norbornyladenine | adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology | ||
| 10008872 | CAY10503 | - | >98% |
|
2007-08-02 | 49.169944751381 | cay10503 | apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic | |||
| 10010301 | CAY10554 | 267654-00-2 | >95% |
|
2007-12-01 | 9.965423572744 | cay10554 | BML-259 | cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases | ||
| 10010043 | CAY10561 Exclusive | 933786-58-4 | >98% |
|
✓ | 2008-03-06 | 4.249723756906 | cay10561 | Pyrazolylpyrrole ERK Inhibitor | MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors | |
| 10011247 | CAY10574 | 140651-18-9 | >95% |
|
2008-09-04 | 14.638066298342 | cay10574 | CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 | |||
| 10011256 | CAY10577 | 300675-28-9 | ≥95% |
|
2008-09-02 | 0.397790055249 | cay10577 | inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers | |||
| 10011264 | CAY10578 | 19231-60-8 | ≥95% |
|
2008-08-26 | 0.397790055249 | cay10578 | inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids | |||
| 13836 | CAY10625 Exclusive New | 137346-42-0 | ≥95% |
|
✓ | 2010-06-23 | 0E-12 | cay10625 | apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo | ||
| 10009349 | Cell Cycle Phase Determination Kit | - | 2007-04-20 | 40.741099984653 | cell-cycle-phase-determination-kit | assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba | |||||
| 10009853 | CFSE Cell Division Assay Kit | - |
|
2010-01-15 | 64.210537139349 | cfse-cell-division-assay-kit | derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein | ||||
| 10010706 |
(−)- |
522-17-8 | >98% |
|
2008-09-18 | 1.759668508287 | -deguelin | (-)-cis-Deguelin | rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K | ||
| 10008422 |
D- |
120965-76-6 | ≥98% |
|
2009-08-04 | 53.600546961325 | d-myo-inositol-1-5-6-triphosphate-sodium-salt | Ins(1,5,6)-P3 (sodium salt); 1,5,6-IP3 (sodium salt) | phosphates IP2 signal transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositol IP3 second messengers trisphosphates PtdIns phosphatidylinositol D-myos PIPS | ||
| 10008419 |
D- |
- | ≥98% |
|
✓ | 2009-08-04 | 50.000336514314 | d-myo-inositol-2-4-diphosphate-sodium-salt | Ins(2,4)-P2 (sodium salt); 2,4-IP2 (sodium salt) | phosphates IP2 signals transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositols IP3 second messengers biphosphates bisphosphates PtsIns phosphatidylinositol 106358-02-5 | |
| 10010302 | DRB | 53-85-0 | >98% |
|
2008-01-21 | 4.171823204420 | drb | Benzimidazole; NSC 401575 | cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat | ||
| 10007806 | Epoxomicin | 134381-21-8 | ≥98% |
|
2008-12-09 | 54.929240331491 | epoxomicin | BU 4061T | inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors | ||
| 10010238 | Erbstatin Analog | 63177-57-1 | ≥98% |
|
2008-06-06 | 0.198895027624 | erbstatin-analog | Methyl 2,5-dihydoxycinnamate | analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers | ||
| 13355 | Geldanamycin New | 30562-34-6 | 98% |
|
2010-07-29 | 3.207182320442 | geldanamycin | NSC 122750 | NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors | ||
| 16834 |
Hexadecanal- |
- | ≥99% deuterated compound |
|
2009-03-02 | 56.942607602475 | hexadecanal-d5 | Palmitaldehyde; 16-Hexadecanal | deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry | ||
| 10530 | Histone H3 Trimethyl Lys9 Peptide New | - | 2010-06-29 | 300.437306629834 | histone-h3-trimethyl-lys9-peptide | H3K9(Me)3 Peptide | JMJD2A JMJC JMJD2D acetylation methylation phosphorylation genes transcription substances regulation H3K9Me3 | ||||
| 10202 | Hsp90α (human recombinant) New | - | ≥80% | 2010-03-16 | 93.359453652547 | hsp90-human-recombinant | Hsp84; Heat Shock Protein 90α | heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a | |||
| 10342 | Hsp90β (human recombinant) New | - | ≥85% | 2010-03-16 | 99.888095238095 | hsp90-human-recombinant | Hsc90; Hsp90 AB1; Heat Shock Protein 90β | heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b | |||
| 13712 |
KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A- |
- | 2009-12-02 | 0E-12 | kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 | antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated | |||||
| 10010239 | Kenpaullone | 142273-20-9 | >98% |
|
2007-09-04 | 18.745782688766 | kenpaullone | NSC 664704; 9-Bromopaullone | GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers | ||
| 9000332 |
Methylcarbamyl PAF C- |
- | ≥98% |
|
✓ | 2009-02-25 | 10.842071823204 | methylcarbamyl-paf-c-8 | Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF | ||
| 13208 | Mirin | 299953-00-7 | ≥95% |
|
2009-04-15 | 69.098425414364 | mirin | DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair | |||
| 13600 | MK 0457 New | 639089-54-6 | ≥98% |
|
2010-08-16 | 0E-12 | mk-0457 | Tozasertib; VX 680 | mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C | ||
| 10009365 | MTT Cell Proliferation Assay Kit | - |
|
2007-02-15 | 85.536528545120 | mtt-cell-proliferation-assay-kit | assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay cell based assay cba | ||||
| 10011255 | NSC 210902 | 51726-83-1 | ≥95% |
|
2008-09-15 | 1.672375690607 | nsc-210902 | Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 | |||
| 13196 | NSC 23766 (hydrochloride) New | 1177865-17-6 | ≥98% |
|
2010-07-20 | 0E-12 | nsc-23766-hydrochloride | 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration angiogenesis leukemia cancers gene expression Rac1 Inhibitor | |||
| 13303 | NSC 663284 New | 383907-43-5 | ≥98% |
|
2010-04-01 | 0E-12 | nsc-663284 | Cdc25 Phosphatase Inhibitor II; DA-3003-1 | dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible | ||
| 18585 |
(−)- |
- | ≥98% |
|
✓ | 2008-08-06 | 143.446160220994 | -nutlin-3 | Nutlin 3a | P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a | |
| 10009816 |
(+)- |
- | ≥98% |
|
✓ | 2008-08-11 | 99.996270718231 | -nutlin-3 | Nutlin 3b | p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b | |
| 13641 |
NVP- |
- | 98% |
|
2010-07-28 | 34.935248618785 | nvp-aew541-hydrochloride | 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 | |||
| 10010240 | Olomoucine | 101622-51-9 | >98% |
|
2007-09-13 | 13.512863720074 | olomoucine | inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle | |||
| 10011301 | p38 MAPK Monoclonal Antibody (Clone 9F12) | - |
|
2008-05-22 | 2.615138121547 | p38-mapk-monoclonal-antibody-clone-9f12 | p38 Mitogen-activated Protein Kinase; p38 MAPKα | serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC | |||
| 700240 | Phosphatidic Acid Assay Kit | - |
|
2009-08-24 | 60.175303867403 | phosphatidic-acid-assay-kit | PA Assay Kit | assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin | |||
| 10011210 | Protein Phosphatase 2A C subunit (human recombinant) Exclusive | - | ≥90% | ✓ | 2008-07-17 | 322.995745856353 | protein-phosphatase-2a-c-subunit-human-recombinant | PP2A Cα | PP2AC.alpha. PP2ACalpha PP2ACa proteins phosphorylation serine threonine phosphatase cell growth cycle differentiation tumor suppressor | ||
| 10011237 | Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive | - | ✓ | 2008-07-17 | 7.620110497237 | protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion | PP2A Cα; PP2A Δ309; PP2A L309 | proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag | |||
| 10008394 |
PtdIns- |
- | >98% |
|
✓ | 2007-06-11 | 23.870697769592 | ptdins-3-p1-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3-monophosphate C-8 (sodium salt); DOPI-3-P1 (sodium salt) | phosphatidyl inositols IP3 diacylglcerol DAG PIP1 PIP2 PIP3 transuction C phospholipase D PLC PLD signaling signalling | |
| 13697 |
(R)- |
- | ≥98% |
|
✓ | 2010-06-22 | 0E-12 | -r-mg132 | ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited | ||
| 10009569 |
(R)- |
186692-46-6 | >98% |
|
2007-09-04 | 27.280174953960 | -r-roscovitine | Seliciclib | cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease | ||
| 10012628 |
(S)- |
133407-82-6 | ≥98% |
|
2009-02-18 | 237.284033149171 | -s-mg132 | 2-Leu-Leu-Leu-CHO | ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO | ||
| 13577 | SU 11652 | 326914-10-7 | ≥95% |
|
2010-02-02 | 66.017581338245 | su-11652 | growth factors receptors tyrosine kinases RTK inhibitors inhibits platelet-derived PDGF PDGF-β vascular endothelial VEGF VEGFR-2 fibroblast FGF FGFR1 epidermal EGFs EGFRs cells cycling apoptosis Kit c-Kit angiogenesis estrogen SU11652 mutants SU-11652 autophosphorylation | |||
| 13338 | SU 6656 | 330161-87-0 | ≥95% |
|
2009-08-04 | 10.202058011049 | su-6656 | inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 | |||
| 13085 |
Tenovin- |
380315-80-0 | ≥98% |
|
✓ | 2008-09-18 | 31.963016574585 | tenovin-1 | histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma | ||
| 13086 |
Tenovin- |
1011557-82-6 | ≥95% |
|
✓ | 2009-02-12 | 46.790469613259 | tenovin-6 | histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs | ||
| 10011619 | Terbinafine (hydrochloride) | 78628-80-5 | ≥98% |
|
2010-02-16 | 69.573707796194 | terbinafine-hydrochloride | antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition | |||
| 13791 | TRF2 Polyclonal Antibody New | - |
|
2010-06-24 | 300.437306629834 | trf2-polyclonal-antibody | TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 | antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis | |||
| 10011251 | TWS119 | 601514-19-6 | ≥90% |
|
2008-12-11 | 143.547255985267 | tws119 | inhibitors inhibits inhibition stem cells differentiation neurogenesis neuron kinases GSK-3β GSK3β TWS 119 TWS-119 | |||
| 13722 |
Ubiquitin Monoclonal Antibody (Clone 5B9- |
- | 2009-12-04 | 0.645454545454 | ubiquitin-monoclonal-antibody-clone-5b9-b3 | antibodies western blots WB blotting immunoblotting ELISA ubiquitination inhibitors proteins IκBα signal transduction | |||||
| 10010591 | Wortmannin | 19545-26-7 | ≥98% |
|
2008-11-21 | 36.766139502762 | wortmannin | KY 12420 | phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK | ||
| 13576 |
YM- |
371942-69-7 | ≥95% |
|
2010-04-14 | 0E-12 | ym-201636 | PIKfyve phosphoinositide kinase PIK zinc finger domains phosphatidylinositol 3-phosphate PI3P PI(3,5)P2 membrane trafficking cytoskeleton inhibitors endosomal trafficking endosomes phagocytosis retrovirus virology adipocytes insulin glucose diabetes YM201636 YM 201636 | |||
| 13601 | ZM 447439 New | 331771-20-1 |
|
2010-08-03 | 0E-12 | zm-447439 | auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search